These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 8226741
1. Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. Knab AM, Fertala J, Bjornsti MA. J Biol Chem; 1993 Oct 25; 268(30):22322-30. PubMed ID: 8226741 [Abstract] [Full Text] [Related]
2. A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons. Knab AM, Fertala J, Bjornsti MA. J Biol Chem; 1995 Mar 17; 270(11):6141-8. PubMed ID: 7890748 [Abstract] [Full Text] [Related]
3. Camptothecin sensitivity is mediated by the pleiotropic drug resistance network in yeast. Reid RJ, Kauh EA, Bjornsti MA. J Biol Chem; 1997 May 02; 272(18):12091-9. PubMed ID: 9115278 [Abstract] [Full Text] [Related]
4. Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin. Bjornsti MA, Knab AM, Benedetti P. Cancer Chemother Pharmacol; 1994 May 02; 34 Suppl():S1-5. PubMed ID: 8070016 [Abstract] [Full Text] [Related]
5. Increased camptothecin toxicity induced in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I. Hann C, Evans DL, Fertala J, Benedetti P, Bjornsti MA, Hall DJ. J Biol Chem; 1998 Apr 03; 273(14):8425-33. PubMed ID: 9525954 [Abstract] [Full Text] [Related]
6. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Benedetti P, Fiorani P, Capuani L, Wang JC. Cancer Res; 1993 Sep 15; 53(18):4343-8. PubMed ID: 8395982 [Abstract] [Full Text] [Related]
7. An engineered mutant of vaccinia virus DNA topoisomerase I is sensitive to the anti-cancer drug camptothecin. Gupta M, Zhu CX, Tse-Dinh YC. J Biol Chem; 1992 Dec 05; 267(34):24177-80. PubMed ID: 1332948 [Abstract] [Full Text] [Related]
8. Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I. Lynn RM, Bjornsti MA, Caron PR, Wang JC. Proc Natl Acad Sci U S A; 1989 May 05; 86(10):3559-63. PubMed ID: 2542938 [Abstract] [Full Text] [Related]
14. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I. Morham SG, Shuman S. J Biol Chem; 1992 Aug 05; 267(22):15984-92. PubMed ID: 1322412 [Abstract] [Full Text] [Related]
15. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin. Wright CM, van der Merwe M, DeBrot AH, Bjornsti MA. J Biol Chem; 2015 May 08; 290(19):12068-78. PubMed ID: 25795777 [Abstract] [Full Text] [Related]
16. Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Bjornsti MA, Benedetti P, Viglianti GA, Wang JC. Cancer Res; 1989 Nov 15; 49(22):6318-23. PubMed ID: 2553253 [Abstract] [Full Text] [Related]
17. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity. Fiorani P, Amatruda JF, Silvestri A, Butler RH, Bjornsti MA, Benedetti P. Mol Pharmacol; 1999 Dec 15; 56(6):1105-15. PubMed ID: 10570037 [Abstract] [Full Text] [Related]